Clinical value of a comprehensive clinical- and echocardiography-based risk score on predicting cardiovascular outcomes in ischemic heart failure patients with reduced ejection fraction

Dan Liu,Kai Hu,Camilla Wagner,Björn Daniel Lengenfelder,Georg Ertl,Stefan Frantz,Peter Nordbeck
DOI: https://doi.org/10.1007/s00392-024-02399-1
IF: 6.138
2024-03-07
Clinical Research in Cardiology
Abstract:Aims The present study aimed to develop a comprehensive clinical- and echocardiography-based risk score for predicting cardiovascular (CV) adverse outcomes in patients with ischemic heart failure (IHF) and reduced left ventricular ejection fraction (LVEF). Methods This retrospective cohort study included 1341 hospitalized patients with IHF and LVEF < 50% at our hospital from 2009 to 2017. Cox regression models and nomogram were utilized to develop a comprehensive prediction model (C&E risk score) for CV mortality and CV-related events (hospitalization or death). Results Over a median 26-month follow-up, CV mortality and CV events rates were 17.4% and 40.9%, respectively. The C&E risk score, incorporating both clinical and echocardiographic factors, demonstrated superior predictive performance for CV outcomes compared to models using only clinical or echocardiographic factors. Internal validation confirmed the stable predictive ability of the C&E risk score, with an AUC of 0.740 (95% CI 0.709–0.775, P < 0.001) for CV mortality and an AUC of 0.678 (95% CI 0.642–0.696, P < 0.001) for CV events. Patients were categorized into low-, intermediate-, and high-risk based on the C&E risk score, with progressively increasing CV mortality (5.3% vs. 14.6% vs. 31.9%, P < 0.001) and CV events (28.8% vs. 38.2% vs. 55.0%, P < 0.001). External validation also confirmed the risk score's prognostic efficacy within additional IHF patient datasets. Conclusion This study establishes and validates the novel C&E risk score as a reliable tool for predicting CV outcomes in IHF patients with reduced LVEF. The risk score holds potential for enhancing risk stratification and guiding clinical decision-making for high-risk patients.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a comprehensive clinical and echocardiographic risk scoring system (C&E risk score) for predicting adverse cardiovascular events in patients with ischemic heart failure (IHF) with reduced ejection fraction. Specifically, the study aims to: 1. **Identify independent clinical and echocardiographic parameters**: By analyzing standard echocardiographic indicators and advanced technical parameters such as global longitudinal strain (GLS), identify independent predictors associated with major adverse cardiovascular events. 2. **Establish and validate the risk scoring model**: Based on the identified independent predictors, develop a comprehensive clinical and echocardiographic risk scoring model (C&E risk score) to improve the prognostic stratification and support for clinical decision - making in IHF patients. ### Research Background With the aging of the population and the progress of heart disease treatment techniques, the prevalence of heart failure (HF) is gradually increasing. Ischemic heart disease plays an important role in heart failure and has a significant impact on the prognosis of patients. Therefore, accurate risk assessment is crucial for optimizing patient management and treatment strategies. However, most of the existing risk scoring models rely only on a single clinical or imaging indicator and fail to fully utilize the comprehensive information of multiple factors. ### Research Methods - **Study population**: A retrospective cohort study, including 1,341 IHF patients hospitalized in our hospital between 2009 and 2017, with a left ventricular ejection fraction (LVEF) lower than 50%. - **Data collection**: Collected the patients' clinical characteristics, laboratory test results and echocardiographic data. - **Statistical analysis**: Used the Cox proportional - hazards regression model for multivariate analysis, determined the independent predictors by step - by - step backward elimination method, and constructed the final C&E risk scoring model. ### Main Findings - **Predictive performance**: The C&E risk score performed well in predicting cardiovascular death and cardiovascular events, with an internally validated AUC of 0.740 (95% CI 0.709 - 0.775, P < 0.001) and 0.678 (95% CI 0.642 - 0.696, P < 0.001), respectively. - **Risk stratification**: According to the C&E risk score, patients were divided into low - risk, medium - risk and high - risk groups, and the cardiovascular mortality and the incidence of cardiovascular events in each group gradually increased. - **External validation**: External validation further confirmed the prognostic efficacy of the C&E risk score. ### Conclusion This study successfully established and validated a new C&E risk scoring model, which has high accuracy in predicting cardiovascular events in IHF patients with reduced ejection fraction, and is helpful for improving risk stratification and guiding clinical decision - making.